Skip to Content

Vincristine Sulfate Injection

Last Updated: April 2, 2018
Status: Current

Vincristine Sulfate Injection

Products Affected - Description
  • Vincasar injection, Teva
    1 mg/mL, 1 mL vial, 1 count (NDC 00703-4402-11)
    1 mg/mL, 2 mL vial, 1 count (NDC 00703-4422-11)


Vincristine injection, Pfizer
1 mg/mL, 1 mL vial, 1 count (NDC 61703-0309-06)
Reason for the Shortage
    • Pfizer has vincristine on shortage due to manufacturing delays.
    • Teva has Vincasar on shortage due to increased demand.
Available Products
  • Vincristine injection, Pfizer
    1 mg/mL, 2 mL vial, 1 count (NDC 61703-0309-16)

Estimated Resupply Dates

    • Pfizer has vincristine 1 mg/mL 1 mL vials on back order and the company estimates a release date of late-May 2018.
    • Teva has Vincasar 1 mg/mL 1 mL and 2 mL vials on allocation. Check wholesaler for availability.

Updated

April 2, March 8, February 25 and 7, January 27, 2018, University of Utah, Drug Information Service. Copyright 2018, Drug Information Service, University of Utah, Salt Lake City, UT.

Hide